Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines
暂无分享,去创建一个
L. Stepanova | Y. Zabrodskaya | L. Tsybalova | K. Vasiliev | A. Kovaleva | A. Korotkov | M. Shuklina | I. Vidyaeva
[1] Mingkai Xu,et al. A recombinant protein containing influenza viral conserved epitopes and superantigen induces broad-spectrum protection , 2021, bioRxiv.
[2] W. Mitzner,et al. Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model , 2021, Journal of Virology.
[3] D. Lapuente,et al. T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine , 2021, Viruses.
[4] N. Lukacs,et al. Harnessing Cellular Immunity for Vaccination against Respiratory Viruses , 2020, Vaccines.
[5] J. de Jonge,et al. Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets , 2020, Communications biology.
[6] B. Seong,et al. Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection , 2020, Expert opinion on drug discovery.
[7] Chi‐Huey Wong,et al. Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes , 2020, Proceedings of the National Academy of Sciences.
[8] Deepali Kumar,et al. T-cell responses following Natural Influenza Infection or Vaccination in Solid Organ Transplant Recipients , 2020, Scientific Reports.
[9] Bin Zhou,et al. Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine , 2020, medRxiv.
[10] А. А. Ковалева,et al. Интраназальная иммунизация рекомбинантным белком на основе М2е-пептида и фрагмента второй субъединицы гемагглютинина вирусов гриппа А индуцирует кросс-протективный гуморальный и Т-клеточный ответ у мышей , 2020 .
[11] J. Taubenberger,et al. Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study , 2020, npj Vaccines.
[12] S. Prakash,et al. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4+ TEM Cells in Asymptomatic Individuals and Protect from Ocular Herpes Infection and Disease in “Humanized” HLA-DR Transgenic Mice , 2020, Journal of Virology.
[13] K. Ladell,et al. Primary EBV Infection Induces an Acute Wave of Activated Antigen-Specific Cytotoxic CD4+ T Cells , 2019, The Journal of Immunology.
[14] X. Saelens. The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines , 2019, The Journal of infectious diseases.
[15] P. Velilla,et al. An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression , 2019, PloS one.
[16] N. Ravin,et al. Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine , 2018, PloS one.
[17] J. Mascola,et al. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem. , 2018, Cold Spring Harbor perspectives in biology.
[18] N. Ravin,et al. Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes , 2018, Journal of Biomedical Science.
[19] M. Savic,et al. Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy , 2017, PloS one.
[20] Catharine I Paules,et al. The Pathway to a Universal Influenza Vaccine. , 2017, Immunity.
[21] J. Mascola,et al. Preferential induction of cross-group influenza A hemagglutinin stem–specific memory B cells after H7N9 immunization in humans , 2017, Science Immunology.
[22] W. Fiers,et al. M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection , 2017, Mucosal Immunology.
[23] H. Frijlink,et al. Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine , 2017, Medicine.
[24] W. Fiers,et al. M2-based influenza vaccines: recent advances and clinical potential , 2017, Expert review of vaccines.
[25] S. Kent,et al. Cytotoxic CD4 T Cells—Friend or Foe during Viral Infection? , 2017, Front. Immunol..
[26] J. Donnelly,et al. Universal influenza vaccines: Shifting to better vaccines , 2016, Vaccine.
[27] M. Potapchuk,et al. A Fusion Protein Based on the Second Subunit of Hemagglutinin of Influenza A/H2N2 Viruses Provides Cross Immunity , 2016, Acta naturae.
[28] L. Que,et al. A Protocol for the Comprehensive Flow Cytometric Analysis of Immune Cells in Normal and Inflamed Murine Non-Lymphoid Tissues , 2016, PloS one.
[29] P. Thomas,et al. Balancing Immune Protection and Immune Pathology by CD8+ T-Cell Responses to Influenza Infection , 2016, Front. Immunol..
[30] D. Tscharke,et al. Sizing up the key determinants of the CD8+ T cell response , 2015, Nature Reviews Immunology.
[31] Yu-Jin Kim,et al. Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines , 2015, Immune network.
[32] Fang Fang,et al. Protection against Multiple Subtypes of Influenza Viruses by Virus-Like Particle Vaccines Based on a Hemagglutinin Conserved Epitope , 2015, BioMed research international.
[33] G. Rimmelzwaan,et al. Virus-specific T cells as correlate of (cross-)protective immunity against influenza. , 2015, Vaccine.
[34] S. Shin,et al. DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8+ T cell responses , 2014, Clinical and experimental vaccine research.
[35] Jonathan J Deeks,et al. Cellular immune correlates of protection against symptomatic pandemic influenza , 2013, Nature Medicine.
[36] G. Rimmelzwaan,et al. Clearance of influenza virus infections by T cells: risk of collateral damage? , 2013, Current opinion in virology.
[37] I. Wilson,et al. A Virus-Like Particle That Elicits Cross-Reactive Antibodies to the Conserved Stem of Influenza Virus Hemagglutinin , 2012, Journal of Virology.
[38] T. Strutt,et al. Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. , 2012, The Journal of clinical investigation.
[39] Deborah M. Brown,et al. Multifunctional CD4 Cells Expressing Gamma Interferon and Perforin Mediate Protection against Lethal Influenza Virus Infection , 2012, Journal of Virology.
[40] J. Oxford,et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans , 2012, Nature Medicine.
[41] A. Osterhaus,et al. Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines , 2011, Journal of biomedicine & biotechnology.
[42] W. Fiers,et al. Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection , 2011, The Journal of Immunology.
[43] R. Varadarajan,et al. Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge , 2010, Proceedings of the National Academy of Sciences.
[44] A. Rosato,et al. Role of CD4+ Cytotoxic T Lymphocytes in the Control of Viral Diseases and Cancer , 2010, International reviews of immunology.
[45] R. Hai,et al. Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins , 2010, PLoS pathogens.
[46] K. Mozdzanowska,et al. Prospects for Universal Influenza Virus Vaccine , 2006, Emerging infectious diseases.
[47] A. Jegerlehner,et al. Influenza A Vaccine Based on the Extracellular Domain of M2: Weak Protection Mediated via Antibody-Dependent NK Cell Activity , 2004, The Journal of Immunology.
[48] C. Paidas,et al. GENETIC CONTRIBUTION TO THE SEPTIC RESPONSE IN A MOUSE MODEL , 2002, Shock.
[49] P. Šebo,et al. Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin. , 2013, Antiviral research.